View in EDS

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply.

Saved in:
Bibliographic Details
Title: Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply.
Authors: Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: vsubbiah@mdanderson.org., Lassen U; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Gasal E; Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA., Burgess P; Global Drug Development, Novartis Pharma, Basel, Switzerland., Wainberg ZA; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
Source: The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. e516.
Publication Type: Letter; Comment
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33152307
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dabrafenib plus trametinib in patients with BRAF<superscript>V600E</superscript>-mutated biliary tract cancer - Authors' reply.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: vsubbiah@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Lassen+U%22">Lassen U</searchLink>; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Gasal+E%22">Gasal E</searchLink>; Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Burgess+P%22">Burgess P</searchLink>; Global Drug Development, Novartis Pharma, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wainberg+ZA%22">Wainberg ZA</searchLink>; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. e516.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33152307
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(20)30625-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e516
    Titles:
      – TitleFull: Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Subbiah V
      – PersonEntity:
          Name:
            NameFull: Lassen U
      – PersonEntity:
          Name:
            NameFull: Gasal E
      – PersonEntity:
          Name:
            NameFull: Burgess P
      – PersonEntity:
          Name:
            NameFull: Wainberg ZA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2020 Nov
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1474-5488
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: The Lancet. Oncology
              Type: main
ResultId 1